首页> 外文期刊>Lipids >Dose-dependent effects of docosahexaenoic Acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
【24h】

Dose-dependent effects of docosahexaenoic Acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.

机译:在他汀类药物治疗的高脂血症受试者中,二十二碳六烯酸补充剂对血脂的剂量依赖性作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of the study was to evaluate potential benefits of docosahexaenoic acid (DHA) rich fish oil supplementation as an adjunct to statin therapy for hyperlipidaemia. A total of 45 hyperlipidaemic patients on stable statin therapy with persistent elevation of plasma triglycerides (averaging 2.2 mmol/L) were randomised to take 4 g/day (n = 15) or 8 g/day (n = 15) of tuna oil or olive oil (placebo, n = 15) for 6 months. Plasma lipids, blood pressure and arterial compliance were assessed initially and after 3 and 6 months in 40 subjects who completed the trial. Plasma triglycerides were reduced 27% by 8 g/day DHA-rich fish oil (P < 0.05) but not by 4 g/day when compared with the placebo and this reduction was achieved by 3 months and was sustained at 6 months. Even though total cholesterol was already well controlled by the statin treatment (mean initial level 4.5 mmol/L), there was a further dose-dependent reduction with fish oil supplementation (r = -0.344, P < 0.05). The extent of total cholesterol reduction correlated (r = -0.44) with the initial total cholesterol levels (P < 0.005). In the subset with initial plasma cholesterol above 3.8 mmol/L, plasma very low density lipoprotein (VLDL), intermediate-density lipoprotein (IDL) and low-density lipoprotein (LDL) were isolated and assayed for cholesterol and apolipoprotein B (apoB) at the commencement of the trial and at 3 months of intervention. Fish oil tended to lower cholesterol and apoB in VLDL and raise both in LDL. There were no changes in IDL cholesterol, IDL apoB and high-density lipoprotein cholesterol. The results demonstrate that DHA-rich fish oil supplementation (2.16 g DHA/day) can improve plasma lipids in a dose-dependent manner in patients taking statins and these changes were achieved by 3 months. Fish oil in addition to statin therapy may be preferable to drug combinations for the treatment of combined hyperlipidaemia.
机译:这项研究的目的是评估富含二十二碳六烯酸(DHA)鱼油作为他汀类药物治疗高脂血症的辅助手段的潜在益处。总共45名接受稳定他汀类药物治疗且血浆甘油三酯持续升高(平均2.2 mmol / L)的高脂血症患者被随机分配为每天服用4 g /天(n = 15)或8 g /天(n = 15)金枪鱼油或橄榄油(安慰剂,n = 15)持续6个月。最初评估了40名完成试验的受试者的血浆脂质,血压和动脉顺应性,分别在3和6个月后进行了评估。与安慰剂相比,血浆甘油三酸酯降低了8%/天,富含DHA的鱼油降低了27%(P <0.05),但降低了4g /天,降低了3个月,并持续了6个月。尽管他汀类药物治疗已经很好地控制了总胆固醇(平均初始水平为4.5 mmol / L),但补充鱼油后剂量进一步降低(r = -0.344,P <0.05)。总胆固醇降低的程度与初始总胆固醇水平相关(r = -0.44)(P <0.005)。在初始血浆胆固醇高于3.8 mmol / L的亚组中,分离血浆超低密度脂蛋白(VLDL),中密度脂蛋白(IDL)和低密度脂蛋白(LDL)并在以下温度测定胆固醇和载脂蛋白B(apoB)试验开始后以及干预3个月后。鱼油倾向于降低VLDL中的胆固醇和apoB,而在LDL中均升高。 IDL胆固醇,IDL apoB和高密度脂蛋白胆固醇没有变化。结果表明,在服用他汀类药物的患者中,富含DHA的鱼油补充剂(2.16 g DHA /天)可以剂量依赖的方式改善血浆脂质,这些变化在3个月内就达到了。除他汀类药物疗法外,鱼油可能比药物组合更适合治疗合并的高脂血症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号